Nothing Special   »   [go: up one dir, main page]

NO981633D0 - Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate - Google Patents

Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate

Info

Publication number
NO981633D0
NO981633D0 NO981633A NO981633A NO981633D0 NO 981633 D0 NO981633 D0 NO 981633D0 NO 981633 A NO981633 A NO 981633A NO 981633 A NO981633 A NO 981633A NO 981633 D0 NO981633 D0 NO 981633D0
Authority
NO
Norway
Prior art keywords
administering
skin
active compound
pharmaceutical
mucosa
Prior art date
Application number
NO981633A
Other languages
English (en)
Other versions
NO981633L (no
Inventor
Lise Sylvest Nielsen
Jens Hansen
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of NO981633D0 publication Critical patent/NO981633D0/no
Publication of NO981633L publication Critical patent/NO981633L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO981633A 1995-10-12 1998-04-08 Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate NO981633L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK115095 1995-10-12
PCT/DK1996/000437 WO1997013528A1 (en) 1995-10-12 1996-10-11 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Publications (2)

Publication Number Publication Date
NO981633D0 true NO981633D0 (no) 1998-04-08
NO981633L NO981633L (no) 1998-06-04

Family

ID=8101575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981633A NO981633L (no) 1995-10-12 1998-04-08 Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate

Country Status (7)

Country Link
EP (1) EP0871489A1 (no)
JP (1) JPH11513393A (no)
AU (1) AU702030B2 (no)
CA (1) CA2231273A1 (no)
FI (1) FI980822A0 (no)
NO (1) NO981633L (no)
WO (1) WO1997013528A1 (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP2001524958A (ja) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ 新規な液晶をベースとする生物接着性薬剤送出系
DE69834038D1 (de) 1997-07-01 2006-05-18 Isis Pharmaceutical Inc Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
JP2001513493A (ja) * 1997-08-09 2001-09-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 経鼻投与用組成物
HU225069B1 (en) * 1997-09-09 2006-06-28 Lyotropic Therapeutics Coated particles, methods of making and using
SE9703458D0 (sv) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
WO1999060012A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
AU7504400A (en) * 1999-08-06 2001-03-05 Max-Delbruck-Centrum Fur Molekulare Medizin Implantable active ingredient depot
WO2001045727A2 (en) * 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Stabilized veterinary compositions comprising more than one antiviral agent
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
IL158006A0 (en) * 2001-04-30 2004-03-28 Trommsdorff Arzneimittel Pharmaceutically active uridine esters
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
JP2007504256A (ja) * 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 生物活性剤の送達のための組成物及び方法
DK1768650T3 (da) 2004-06-04 2008-09-29 Camurus Ab Flydende depotformuleringer
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
SI1845942T1 (sl) 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
JP5171262B2 (ja) * 2005-01-14 2013-03-27 カムルス エービー ソマトスタチン類似体製剤
EP1845942B1 (en) * 2005-01-14 2014-04-09 Camurus Ab Gnrh analogue formulations
DE602005026998D1 (de) 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
KR101245022B1 (ko) 2005-01-21 2013-03-19 카무러스 에이비 약제학적 지질 조성물
CN101170997A (zh) * 2005-05-10 2008-04-30 诺瓦提斯公司 改进释放的泛昔洛韦药物组合物
US8546326B2 (en) 2005-06-06 2013-10-01 Camurus Ab Glp-1 analogue formulations
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008049020A2 (en) 2006-10-17 2008-04-24 Nuvo Research Diclofenac gel
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
CA2727299C (en) * 2008-06-09 2017-02-14 Boehringer Ingelheim International Gmbh Device and method for determining the properties of aerosol formulations
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
EP2498754B1 (en) 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonal mesophases (h ii) and uses thereof
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
EA035495B1 (ru) 2012-05-25 2020-06-25 Камурус Аб Состав-предшественник, содержащий агонист рецепторов соматостатина, способ лечения путем его введения, его применение, предварительно заполненное устройство, содержащее его, и набор, содержащий указанное устройство
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
RS61377B1 (sr) 2012-07-26 2021-02-26 Camurus Ab Opioidne formulacije
WO2018191794A1 (en) 2017-04-20 2018-10-25 Zeenar Enterprises Pty Ltd Liquid crystalline dosage form for administering a statin
US20210330794A1 (en) * 2018-09-07 2021-10-28 Farnex Incorporated External preparation comprising non-lamellar liquid crystal-forming lipid
WO2020082137A1 (en) * 2018-10-25 2020-04-30 Zeenar Enterprises Pty Ltd Composition that forms liquid crystalline particles
CN111821254B (zh) * 2019-04-18 2021-10-15 华东师范大学 一种抗病毒水凝胶及其制备方法和应用
CN111759858B (zh) * 2020-06-02 2022-09-20 杭州英健生物科技有限公司 pH敏感型消化道粘膜保护胶及其应用
CN112791047A (zh) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 一种白藜芦醇层状液晶及其制备方法
AU2022369377A1 (en) * 2021-10-19 2024-05-30 Sensach Ab Lipid patch
WO2023189273A1 (ja) * 2022-03-28 2023-10-05 富士フイルム株式会社 生体用組成物
WO2023189270A1 (ja) * 2022-03-28 2023-10-05 富士フイルム株式会社 生体用組成物
WO2024068672A1 (en) * 2022-09-26 2024-04-04 Universität Bern Structured lipid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631282A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
EP0448091B1 (en) * 1990-03-23 1998-08-05 The Green Cross Corporation Pharmaceutical composition containing slightly water-soluble drug
AU685262B2 (en) * 1994-03-30 1998-01-15 Gs Development Ab Use of fatty acid esters as bioadhesive substances

Also Published As

Publication number Publication date
EP0871489A1 (en) 1998-10-21
WO1997013528A1 (en) 1997-04-17
AU7279296A (en) 1997-04-30
FI980822A (fi) 1998-04-09
CA2231273A1 (en) 1997-04-17
AU702030B2 (en) 1999-02-11
JPH11513393A (ja) 1999-11-16
FI980822A0 (fi) 1998-04-09
NO981633L (no) 1998-06-04

Similar Documents

Publication Publication Date Title
NO981633D0 (no) Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate
IS2537B (is) Lyfjablanda til inngjafar um húð
DE3774468D1 (de) Arzneimittel fuer periodontale erkrankungen.
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
KR950703383A (ko) 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
NL194780B (nl) Oraal therapeutisch systeem voor toediening van een anticonvulsivum.
AU6273796A (en) Nucleotide analogues for topical treatment of proliferative disease of the skin
NO974480D0 (no) Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
AU4778893A (en) System of drug delivery to the lymphatic tissues
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
AU4048295A (en) Peptide medicaments for the treatment of disease
NO173873C (no) Analogifremgangsmaate til fremstilling av en terapeutisk aktiv monosakkaridforbindelse
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
AU6934691A (en) Transdermal administration of zwitterionic drugs
PT801561E (pt) Composicao e metodos para a entrega transdermica de drogas labeis a acido
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE3874072D1 (de) Arzneimittel fuer die kombination piperidinoalkanol-dekongestivum.
HK1005131A1 (en) Improvement of physiological tolerance of pharmaceutical active beta-amio acids
DE3786199D1 (de) Artikel fuer die verabreichung pharmakologisch aktiver substanzen.
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application